Effect of cytochrome P-450 induction and inhibition on the antihypertensive function of the kidney.
Muirhead
E
E
Department of Pathology, University of Tennessee, Memphis 38163.
Byers
L W
LW
Capdevila
J
J
Brooks
B
B
Pitcock
J A
JA
Brown
P
P
Dowell
R
R
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002995:Clofibric Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D065607:Cytochrome P-450 Enzyme Inhibitors; D003577:Cytochrome P-450 Enzyme System / Q000096:biosynthesis*; D004790:Enzyme Induction; D058607:Fibric Acids; D006978:Hypertension, Renovascular / Q000473:pathology / Q000503:physiopathology*; D006984:Hypertrophy; D000960:Hypolipidemic Agents / Q000494:pharmacology; D008099:Liver / Q000187:drug effects / Q000201:enzymology* / Q000473:pathology; D008297:Male; D010634:Phenobarbital / Q000494:pharmacology / Q000633:toxicity; D011335:Proadifen / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D012016:Reference Values
D065607:Cytochrome P-450 Enzyme Inhibitors; D058607:Fibric Acids; D000960:Hypolipidemic Agents; D002995:Clofibric Acid; D003577:Cytochrome P-450 Enzyme System; D011335:Proadifen; C019304:ciprofibrate; D010634:Phenobarbital